As of today (2024-04-24), 10x Genomics's share price is $27.52.
10x Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.56. Hence, 10x Genomics's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for 10x Genomics's Price-to-Free-Cash-Flow or its related term are showing as below:
TXG's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 18.22 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 39.80% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -5.90% per year.
During the past 7 years, 10x Genomics's highest 3-Year average Free Cash Flow per Share Growth Rate was 39.80% per year. The lowest was -144.20% per year. And the median was -47.30% per year.
10x Genomics Price-to-Free-Cash-Flow Historical Data
The historical data trend for 10x Genomics's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of 10x Genomics's Price-to-Free-Cash-Flow
For the Health Information Services subindustry, 10x Genomics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
10x Genomics's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where 10x Genomics's Price-to-Free-Cash-Flow falls into.
10x Genomics Price-to-Free-Cash-Flow Calculation
10x Genomics's Price-to-Free-Cash-Flow ratio for today is calculated as
10x Genomics's Share Price of today is $27.52.
10x Genomics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
10x Genomics Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of 10x Genomics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TXG has been successfully added to your 